Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2014
03/18/2014CA2576275C Multiparticulates with controlled release properties and free of lubricant
03/18/2014CA2543534C Method for transdermal delivery of permeant substances
03/18/2014CA2469588C Highly concentrated stable meloxicam solutions for needleless injection
03/17/2014CA2826786A1 Multi-encapsulated formulations made with oxidized cellulose
03/13/2014WO2014040087A1 A virucidal small molecule and uses thereof
03/13/2014WO2014039951A1 Enteral pharmaceutical compositions
03/13/2014WO2014039874A2 Methods and materials for reducing reticuloendothelial system clearance of particles from a subject
03/13/2014WO2014039781A1 Treating hearing loss
03/13/2014WO2014039677A1 Coated pharmaceutical composition containing regorafenib
03/13/2014WO2014039668A1 Non-pegylated liposomal doxorubicin combinations for the treatment of triple-negative breast cancer
03/13/2014WO2014039635A1 Formulations of selective alpha-2 agonists and methods of use thereof
03/13/2014WO2014039557A1 Wound dressing
03/13/2014WO2014039504A1 Bolaamphiphilic compounds, compositions and uses thereof
03/13/2014WO2014039503A1 Bolaamphiphilic compounds, compositions and uses thereof
03/13/2014WO2014039502A1 Bolaamphiphilic compounds, compositions and uses thereof
03/13/2014WO2014039501A1 Bolaamphiphilic compounds, compositions and uses thereof
03/13/2014WO2014039500A1 Bolaamphiphilic compounds, compositions and uses thereof
03/13/2014WO2014039245A1 Method of creating hydrogels through oxime bond formation
03/13/2014WO2014039237A1 Sunscreen sheet
03/13/2014WO2014039185A1 Polymeric nanoparticles in a thermosensitive gel for coital-independent vaginal prophylaxis of hiv
03/13/2014WO2014039012A1 Hyaluronic acid-based drug delivery systems
03/13/2014WO2014039001A1 Tiotropium preparations
03/13/2014WO2014038895A1 Solid oral dosage form containing valsartan, and preparation method therefor
03/13/2014WO2014038829A1 Method for selectively activating magnetic nanoparticle and selectively activated magnetic nanoparticle
03/13/2014WO2014038593A2 Granulated material for tablet that rapidly disintegrates in mouth
03/13/2014WO2014038558A1 Molecular assembly using branched amphiphilic block polymer, and drug transportation system
03/13/2014WO2014038168A1 Functional substance, method for permeating bioactivating agent and functional substance into living body, functional substance-dispersing device, and air cleaner
03/13/2014WO2014038004A1 Slow-drug-release ophthalmic lens and manufacturing method therefor
03/13/2014WO2014037942A1 Use of decellularized extracellular matrix for encapsulating cells
03/13/2014WO2014037883A1 Topical antimicrobial formulations
03/13/2014WO2014037727A1 Carcainium salts
03/13/2014WO2014037726A1 Liquid pharmaceutical compositions
03/13/2014WO2014037680A1 High concentration aqueous protein solution having reduced viscosity
03/13/2014WO2014037596A1 Release of substances into senescent cells
03/13/2014WO2014037436A1 Lipid assemblies comprising anionic lysolipids and use thereof
03/13/2014WO2014037343A1 Composition for treating psoriasis
03/13/2014WO2014037022A1 Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
03/13/2014WO2014036808A1 Plant beneficial to liver and use thereof
03/13/2014WO2014036649A1 Rapid formation of chitosan sponges using guanosine 5' -diphosphate: injectable scaffolds for tissue regeneration and drug delivery
03/13/2014WO2014036620A1 Process for manufacturing a product for treating psoriasis and product for treating psoriasis
03/13/2014WO2014016754A3 Pharmaceutical compositions of proton pump inhibitor
03/13/2014WO2014016671A3 Formulations and methods of manufacturing formulations for use in colonic evacuation
03/13/2014WO2014011895A3 High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof
03/13/2014WO2014007781A3 Inhalation compositions
03/13/2014WO2014007771A3 Inhalation compositions comprising muscarinic receptor antagonist
03/13/2014WO2012119102A3 Homeopathic therapeutic method and compositions
03/13/2014WO2012092420A3 Methods for cryopreserving and encapsulating cells
03/13/2014US20140074067 Intravaginal devices for controlled delivery of lubricants
03/13/2014US20140074066 Device and method for treating the anal sphincter
03/13/2014US20140073665 Modified release compositions comprising tacrolimus
03/13/2014US20140073663 Method of providing sustained analgesia with buprenorphine
03/13/2014US20140073619 Method for treating chronic pain
03/13/2014US20140073570 Pharmaceutical composition and methods for peptide treatment
03/13/2014US20140073562 Nasal delivery
03/13/2014US20140072646 Thyroid hormone analogs and methods of use
03/13/2014US20140072644 Anti-misuse microparticulate oral pharmaceutical form
03/13/2014US20140072643 Methods of treating cancer
03/13/2014US20140072641 Method for the realisation of a biomaterial comprising calcium phosphate shaped as granules and/or their agglomerates and biomaterial obtained with this method
03/13/2014US20140072640 Coating Method
03/13/2014US20140072639 Nanolipidic particle assembly populations
03/13/2014US20140072637 Treatment for bone formation disorders by growth factor delivery
03/13/2014US20140072632 Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography
03/13/2014US20140072629 Biologic matrices comprising anti-infective, methods and compositions related thereto
03/13/2014US20140072628 Stable pharmaceutical composition of saxagliptin
03/13/2014US20140072626 Once daily formulations of tetracyclines
03/13/2014US20140072625 Gastric Reflux Resistant Dosage Forms
03/13/2014US20140072624 Unit dose form for oral administration
03/13/2014US20140072623 Gastric retained gabapentin dosage form
03/13/2014US20140072621 Composition and method to improve intestinal health
03/13/2014US20140072620 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
03/13/2014US20140072618 Topical delivery of l-arginine to cause beneficial effects
03/13/2014US20140072616 Lyophilization of Virosomes
03/13/2014US20140072615 Transdermal hormone delivery system: compositions and methods
03/13/2014US20140072614 Rapidly acting dry sealant and methods for use and manufacture
03/13/2014US20140072612 Rolled collagen carrier
03/13/2014US20140072608 Method for production of nanoporous multi-layer biodegradable polymeric coatings and products thereof
03/13/2014US20140072607 Polycarbonates bearing pendant primary amines for medical applications
03/13/2014US20140072605 Substrates for Drug Delivery Device and Methods of Preparing and Use
03/13/2014US20140072604 Block Copolymer For Intraperitoneal Administration Containing Anti-Cancer Agent, Micelle Preparation Thereof, And Cancer Therapeutic Agent Comprising The Micelle Preparation As Active Ingredient
03/13/2014US20140072602 Micelle encapsulation of a combination of therapeutic agents
03/13/2014US20140072531 Method for preparing microparticles with reduced initial burst and microparticles prepared thereby
03/13/2014US20140072518 Polytetrafluoroethylene co-polymer emulsions
03/13/2014US20140070446 Sustained-release solid preparation for oral use
03/13/2014DE102012108560A1 Nichtkovalente selbstorganisierende Hydrogelmatrix für biotechnologische Anwendungen Non-covalent self-assembling hydrogel matrix for biotechnological applications
03/12/2014EP2706108A1 Semi-transparent fragrance composition
03/12/2014EP2705847A1 Composition for treating psoriasis
03/12/2014EP2705839A1 Pharmaceutical composition comprising lacidipine and process of preparation
03/12/2014EP2705838A1 Tiotropium preparations
03/12/2014EP2705837A1 Diclofenac Formulation
03/12/2014EP2705836A1 Pharmaceutical compositions having desirable bioavailability
03/12/2014EP2705835A1 Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release
03/12/2014EP2705182A1 Fiber comprising a biodegradable polymer
03/12/2014EP2704756A1 Wound treatment
03/12/2014EP2704750A2 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
03/12/2014EP2704748A1 Bis-(alpha-amino-diol-diester) containing polyesteramide for ophtamology
03/12/2014EP2704742A2 Formulation for anti- 4 7 antibody
03/12/2014EP2704729A1 Antimicrobial silver hydrogel composition for the treatment of burns and wounds
03/12/2014EP2704727A2 Skin and hair regeneration using polysaccharide-based hydrogels
03/12/2014EP2704724A1 Improved suspension formulation of a corticosteroid for administration by inhalation
03/12/2014EP2704715A2 Tolerogenic synthetic nanocarriers for generating cd8+regulatory t cells
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 2991